The association between TCM syndromes and SCAP polymorphisms in subjects with non-alcoholic fatty liver disease

Milić, 2012, Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment, Dig Dis, 30, 158, 10.1159/000336669 Vernon, 2011, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults, Aliment Pharmacol Ther, 34, 274, 10.1111/j.1365-2036.2011.04724.x Fan, 2005, Prevalence of and risk factors for fatty liver in a general population of Shanghai, China, J Hepatol, 43, 508, 10.1016/j.jhep.2005.02.042 Chen, 2011, Relationship between nonalcoholic fatty liver disease and metabolic syndrome, J Dig Dis, 12, 125, 10.1111/j.1751-2980.2011.00487.x Juran, 2006, Genomics and complex liver disease: challenges and opportunities, Hepatology, 44, 1380, 10.1002/hep.21453 Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775 Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 55, 2005, 10.1002/hep.25762 Hotta, 2010, Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease, BMC Med Genet, 11, 172, 10.1186/1471-2350-11-172 Zhou, 2010, Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people, J Gastroenterol Hepatol, 25, 772, 10.1111/j.1440-1746.2009.06144.x Yoneda, 2008, Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD), BMC Gastroenterol, 8, 27, 10.1186/1471-230X-8-27 Wanless, 1990, Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors, Hepatology, 12, 1106, 10.1002/hep.1840120505 Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J Clin Invest, 109, 1125, 10.1172/JCI0215593 Miserez, 1997, Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2), Genomics, 40, 31, 10.1006/geno.1996.4525 Matsuda, 2001, SERBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation, Genes Dev, 15, 1206, 10.1101/gad.891301 Goldstein, 2002, Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis, Arch Biochem Biophys, 397, 139, 10.1006/abbi.2001.2615 Sakai, 1998, Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies, J Biol Chem, 273, 5785, 10.1074/jbc.273.10.5785 Zeng, 2008, Chinese National Consensus Workshop on Nonalcoholic Fatty Liver Disease. Chinese National Consensus Workshop on Nonalcoholic Fatty Liver Disease. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases, J Dig Dis, 9, 108, 10.1111/j.1751-2980.2008.00331.x Zhu, 1994 Carlson, 2004, Selecting a maximally informative set of singlenucleotide polymorphisms for association analyses using linkage disequilibrium, Am J Hum Genet, 74, 106, 10.1086/381000 Xie, 2012, Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia, J Ethnopharmacol, 140, 345, 10.1016/j.jep.2012.01.027 Chen, 2011, Lipid-lowering and antioxidant activities of Jiang-Zhi-Ning in Traditional Chinese Medicine, J Ethnopharmacol, 134, 919, 10.1016/j.jep.2011.01.048 Shi, 2012, Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis, Mol Biol Rep, 39, 9715, 10.1007/s11033-012-1836-0 Lu, 2012, An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis, J Ethnopharmacol, 141, 549, 10.1016/j.jep.2011.08.045 Li, 2007, Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network, IET Syst Biol, 1, 51, 10.1049/iet-syb:20060032 He, 2007, Relations between serum IgA level and cartilage erosion in 436 cases of rheumatoid arthritis, Immunol Investig, 36, 285, 10.1080/08820130601069731 Liu, 2011, Observations on copy number variations in a Kidney-yang Deficiency Syndrome Family, Evid Based Complement Alternat Med, 2011, 548358, 10.1093/ecam/neq069 Wu, 2010, Polymorphisms in PPARD, PPARG and APM1 associated with four types of Traditional Chinese Medicine constitutions, J Genet Genomics, 37, 371, 10.1016/S1673-8527(09)60055-2 Korn, 1998, Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N), J Clin Invest, 102, 2050, 10.1172/JCI5341 Motamed, 2011, Identification of luminal Loop 1 of Scap protein as the sterol sensor that maintains cholesterol homeostasis, J Biol Chem, 286, 18002, 10.1074/jbc.M111.238311 Brown, 2009, Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL, J Lipid Res, 50, S15, 10.1194/jlr.R800054-JLR200 Hua, 1996, Sterol resistance in CHO cells traced to point mutation in SREBP cleavage activating protein (SCAP), Cell, 87, 415, 10.1016/S0092-8674(00)81362-8 Wang, 2011, Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs, Pharmacogenomics J, 11, 274, 10.1038/tpj.2010.28 Elgazzar, 2012, A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese, J Hum Genet, 108